Oral melanomas are the most frequent tumors of the mouth in our dog patients. Even if treated with very aggressive therapies, they often lead to the animal's death.
A new vaccine, developed and commercialized in the United States, offers a completely new therapeutic approach and promises much longer survival times.
The AOI Center was the first European oncological institute that was authorized to import and use this vaccine.
More information on the melanoma vaccine
Superficial tumors: new immunotherapy
We apply a novel immunotherapy in the context of a clinical study in collaboration with the ETH Zürich. Don't hesitate to contact us for further information: email@example.com